Scleroderma is not hereditary in the traditional sense. It does not follow a predictable inheritance pattern, and most cases occur in people with no family history of the condition. However, genetics do play a role: having a first-degree relative with scleroderma raises your risk roughly 13-fold compared to the general population. That sounds dramatic, but because scleroderma is so rare to begin with (affecting fewer than 1 in 1,000 people), even a 13-fold increase translates to an absolute risk of about 0.08%, or less than 1 in 1,000.
Why It Runs in Families but Isn’t Inherited
Scleroderma is what geneticists call a complex polygenic disease. Rather than being caused by a single gene mutation passed from parent to child, it involves dozens of small genetic variations, each contributing a modest bump in risk. On top of that, environmental exposures and random biological events have to line up for the disease to actually develop. Inheriting a gene variant linked to scleroderma does not mean you will develop it.
Twin studies illustrate this clearly. Identical twins share virtually all their DNA, yet when one twin has scleroderma, the other develops it only a small fraction of the time. The concordance rate for the disease itself is low. What is strikingly higher in identical twins is the presence of certain immune antibodies associated with scleroderma, suggesting that genetics prime the immune system in a particular direction without guaranteeing disease.
The Genetic Variations That Raise Risk
The strongest genetic links involve a cluster of immune-system genes that help your body distinguish its own cells from invaders. One particular variant in this region nearly triples the odds of developing scleroderma (an odds ratio of 2.81). Other variants in the same gene family appear to be protective, cutting the risk roughly in half. These immune-related genes influence which specific antibodies a person produces, and those antibodies, in turn, help determine which subtype of scleroderma someone develops and which organs are most affected.
Outside of these immune genes, researchers have identified additional risk variants in genes that regulate inflammation signaling. Two of the most consistently replicated are involved in interferon signaling (part of the body’s antiviral defense system) and a pathway that activates immune cells. Carrying risk variants in these genes raises the odds of scleroderma by about 30 to 48 percent. Interestingly, one of these variants, while increasing overall scleroderma risk, appears to protect against lung scarring in people who already have the disease.
Ethnicity and Genetic Susceptibility
Genetic risk is not evenly distributed across populations. Black individuals carry certain gene variants at higher frequencies that are associated with increased production of proteins involved in scarring and inflammation. One variant leads to higher levels of a growth factor that drives tissue fibrosis, the hallmark of scleroderma. Another variant, more common in Black populations, is linked to greater production of an inflammatory signaling molecule. These genetic differences help explain why scleroderma tends to be more common and more severe in Black patients compared to White patients, though environmental and socioeconomic factors also contribute.
Environmental Triggers Matter as Much as Genes
Genetics load the gun, but environmental exposures often pull the trigger. Several occupational and chemical exposures have been linked to scleroderma onset in genetically susceptible people. These include silica dust (common in mining, sandblasting, and construction), organic solvents (used in painting, degreasing, and dry cleaning), welding fumes, pesticides, and epoxy resins. Silicone breast implants and certain viral infections have also been implicated.
Researchers are beginning to understand how these exposures interact with specific gene variants. In one study, silica particles triggered a scarring response in skin cells carrying a particular genetic variant, while cells without that variant responded normally. This kind of gene-environment interaction explains why two people with the same occupational exposure can have very different outcomes. The exposure alone is not enough, and neither is the gene variant alone. Both have to be present.
The Autoimmune Family Connection
Even when scleroderma itself doesn’t run in a family, other autoimmune diseases often do. People with scleroderma frequently have close relatives with conditions like lupus, rheumatoid arthritis, or thyroid disease. This pattern suggests that what’s inherited is not scleroderma specifically but a broader tendency toward immune system dysregulation. The shared genetic variants across these conditions support this idea: many of the same immune-related gene variants that raise scleroderma risk also appear in lupus and rheumatoid arthritis.
Is Genetic Testing Useful?
There is currently no clinical genetic test that can predict whether you will develop scleroderma. Because the disease involves so many small-effect gene variants interacting with environmental factors, no single test or panel can give a meaningful yes-or-no answer. The identified variants each raise risk modestly, and most people who carry them never develop the condition.
What doctors do test for are the specific antibodies associated with scleroderma subtypes, but this is done after symptoms appear, not as a predictive screen. Anticentromere antibodies are linked to the limited form of the disease, which primarily affects the skin on the hands and face along with the digestive tract and lungs. Antitopoisomerase antibodies are associated with the diffuse form, which involves more widespread skin thickening and a higher risk of kidney and heart involvement. These antibody profiles, which are partly determined by your genetic makeup, help guide monitoring and treatment once a diagnosis is made.
If you have a family member with scleroderma, your absolute risk remains very low. The most practical step is simply being aware of early signs, particularly Raynaud’s phenomenon (fingers turning white or blue in cold temperatures), unexplained skin tightening, or persistent swelling in the hands, so that if symptoms do develop, they’re caught early.